Traws Pharma, Inc. (TRAW) Shareholders’ equity 2015–2024
Traws Pharma, Inc. (TRAW) shareholders’ equity at each fiscal year-end, per SEC filings.
-$629,000FY2024 · since FY2015: $4.3M → -$629,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$629,000 | +98.0% |
| FY2023 | -$31.6M | -396.4% |
| FY2022 | $10.7M | -62.3% |
| FY2021 | $28.3M | -38.6% |
| FY2020 | $46.1M | +646.9% |
| FY2019 | $6.2M | -46.6% |
| FY2018 | $11.6M | +114.9% |
| FY2017 | $5.4M | +146.1% |
| FY2016 | -$11.7M | -372.1% |
| FY2015 | $4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice